SPI Pharma Drug For Further Processing
NDC Database
SPI Pharma Drug For Further Processing
NDC Database
National Drug Code (NDC) records including drug products, NDC numbers, nonproprietary names, dosage forms, strengths, labelers and marketing information.
- Total Records 15
- Latest Marketing Date 2026-01-14
- Data Source FDA
- First Marketing Date 2014-06-06
Company Overview
Company
SPI Pharma Drug For Further Processing
Country
U.S.A
Website
Social Profiles
Company Snapshot
SPI Pharma Drug For Further Processing
Rockwood Office Park, 503 Carr Rd., Suite 210, Wilmington, DE 19809
U.S.A
www.spipharma.com/en/ salesinfo@spipharma.com View on MapNDC Records ( 15 records )
Nonproprietary Name
Magaldrate
Dosage Form
POWDER
Strength
98 kg/100kg
Labeler
SPI Pharma
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
MAGALDRATE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2014-06-06
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Magaldrate
Dosage Form
POWDER
Strength
98 kg/100kg
Labeler
SPI Pharma
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
MAGALDRATE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2020-01-23
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Aluminum Hydroxide, Magnesium Carbonate
Dosage Form
POWDER
Strength
64; 16 kg/100kg; kg/100kg
Labeler
SPI PHARMA
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
ALUMINUM HYDROXIDE; MAGNESIUM HYDROXIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2015-06-30
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Aluminum Hydroxide, Magnesium Carbonate
Dosage Form
POWDER
Strength
64; 16 kg/100kg; kg/100kg
Labeler
SPI PHARMA
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
ALUMINUM HYDROXIDE; MAGNESIUM HYDROXIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2015-06-30
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Aluminum Hydroxide
Dosage Form
GEL
Strength
12 kg/100kg
Labeler
SPI PHARMA
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
ALUMINUM HYDROXIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2020-01-24
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Aluminum, Magnesium
Dosage Form
SUSPENSION
Strength
8.6; .025; 11.2 kg/100kg; kg/100kg; kg/100kg
Labeler
SPI PHARMA
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
ALUMINUM HYDROXIDE; BUTYLPARABEN; MAGNESIUM HYDROXIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2023-01-17
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Aluminum Hydroxide
Dosage Form
GEL
Strength
11 kg/100kg
Labeler
SPI PHARMA
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
ALUMINUM HYDROXIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2016-01-28
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Aluminum, Magnesium
Dosage Form
SUSPENSION
Strength
8.9; 11.8 kg/100kg; kg/100kg
Labeler
SPI PHARMA
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
ALUMINUM HYDROXIDE; MAGNESIUM HYDROXIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2020-01-24
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Aluminum, Magnesium
Dosage Form
LIQUID
Strength
8.9; 11.8 kg/100kg; kg/100kg
Labeler
SPI PHARMA
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
ALUMINUM HYDROXIDE; MAGNESIUM HYDROXIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2020-01-27
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Aluminum Hydroxide, Magnesium Carbonate
Dosage Form
POWDER
Strength
5.9; 1.1 kg/100kg; kg/100kg
Labeler
SPI PHARMA
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
ALUMINUM HYDROXIDE; MAGNESIUM CARBONATE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2020-01-28
End Marketing Date
-
Listing Record Certified Through
2027-12-31
Nonproprietary Name
Aluminum Hydroxide, Magnesium Carbonate
Dosage Form
POWDER
Strength
5.9; 1.1 kg/100kg; kg/100kg
Labeler
SPI PHARMA
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
ALUMINUM HYDROXIDE; MAGNESIUM CARBONATE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2023-08-04
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Aluminum Hydroxide Magnesium Hydroxide
Dosage Form
POWDER
Strength
35.4; 35.4 kg/100kg; kg/100kg
Labeler
SPI Pharma
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
ALUMINUM HYDROXIDE; MAGNESIUM HYDROXIDE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2026-01-14
End Marketing Date
-
Listing Record Certified Through
2027-12-31
Nonproprietary Name
Calcium Carbonate
Dosage Form
POWDER
Strength
58 kg/100kg
Labeler
SPI Pharma Inc
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
CALCIUM CARBONATE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2020-01-29
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Ibuprofen
Dosage Form
GRANULE
Strength
93.6 kg/100kg
Labeler
SPI Pharma Inc
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
IBUPROFEN
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2022-06-24
End Marketing Date
-
Listing Record Certified Through
2026-12-31
Nonproprietary Name
Calcium Carbonate
Dosage Form
GRANULE
Strength
95 kg/100kg
Labeler
SPI Pharma Inc
Marketing Category
DRUG FOR FURTHER PROCESSING
Substance
CALCIUM CARBONATE
Product Type
DRUG FOR FURTHER PROCESSING
DEA Schedule
Start Marketing Date
2026-01-13
End Marketing Date
-
Listing Record Certified Through
2027-12-31
NDC Type Breakdown
15 total- Drug for Further Processing
Official Source
NDC data is based on publicly available National Drug Code information from the U.S. Food and Drug Administration (FDA).
Visit FDA NDC DirectoryNDC Record Details Preview
Explore important National Drug Code information available in the records above.
NDC
12784-204
Nonproprietary Name
Magaldrate
Labeler
SPI Pharma
Dosage Form
POWDER
FDA NDC Data
National Drug Code information
Regular Updates
Data maintained from official sources
Structured Database
Searchable pharmaceutical data
Reliable Data
Organized NDC records
Create a New Buying Request
Fields marked with * are mandatory.